State Street’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.54B Buy
4,832,002
+42,343
+0.9% +$22.2M 0.1% 191
2025
Q1
$3.04B Sell
4,789,659
-42,580
-0.9% -$27M 0.13% 153
2024
Q4
$3.44B Sell
4,832,239
-70,165
-1% -$50M 0.14% 136
2024
Q3
$5.15B Buy
4,902,404
+61,277
+1% +$64.4M 0.21% 85
2024
Q2
$5.09B Sell
4,841,127
-421
-0% -$442K 0.22% 81
2024
Q1
$4.66B Sell
4,841,548
-59,703
-1% -$57.5M 0.21% 93
2023
Q4
$4.3B Buy
4,901,251
+72,145
+1% +$63.4M 0.21% 91
2023
Q3
$3.97B Sell
4,829,106
-161,764
-3% -$133M 0.22% 89
2023
Q2
$3.59B Buy
4,990,870
+97,254
+2% +$69.9M 0.19% 102
2023
Q1
$4.02B Sell
4,893,616
-67,269
-1% -$55.3M 0.23% 91
2022
Q4
$3.58B Sell
4,960,885
-90,874
-2% -$65.6M 0.21% 97
2022
Q3
$3.48B Sell
5,051,759
-78,876
-2% -$54.3M 0.22% 89
2022
Q2
$3.03B Buy
5,130,635
+5,168
+0.1% +$3.05M 0.18% 110
2022
Q1
$3.58B Buy
5,125,467
+325,645
+7% +$227M 0.18% 111
2021
Q4
$3.03B Buy
4,799,822
+159,817
+3% +$101M 0.14% 131
2021
Q3
$2.81B Buy
4,640,005
+123,289
+3% +$74.6M 0.15% 128
2021
Q2
$2.52B Sell
4,516,716
-30,585
-0.7% -$17.1M 0.13% 141
2021
Q1
$2.15B Sell
4,547,301
-144,086
-3% -$68.2M 0.12% 159
2020
Q4
$2.27B Buy
4,691,387
+33,849
+0.7% +$16.4M 0.14% 141
2020
Q3
$2.61B Buy
4,657,538
+105,873
+2% +$59.3M 0.18% 109
2020
Q2
$2.84B Buy
4,551,665
+934,332
+26% +$583M 0.21% 94
2020
Q1
$1.77B Buy
3,617,333
+43,216
+1% +$21.1M 0.15% 132
2019
Q4
$1.34B Buy
3,574,117
+44,258
+1% +$16.6M 0.09% 213
2019
Q3
$979M Buy
3,529,859
+57,027
+2% +$15.8M 0.07% 275
2019
Q2
$1.09B Buy
3,472,832
+7,781
+0.2% +$2.44M 0.08% 244
2019
Q1
$1.42B Buy
3,465,051
+192,343
+6% +$79M 0.11% 190
2018
Q4
$1.22B Buy
3,272,708
+39,487
+1% +$14.7M 0.11% 185
2018
Q3
$1.31B Sell
3,233,221
-7,181
-0.2% -$2.9M 0.1% 197
2018
Q2
$1.12B Sell
3,240,402
-59,113
-2% -$20.4M 0.09% 212
2018
Q1
$1.14B Sell
3,299,515
-22,457
-0.7% -$7.73M 0.1% 212
2017
Q4
$1.25B Buy
3,321,972
+77,548
+2% +$29.2M 0.1% 205
2017
Q3
$1.45B Sell
3,244,424
-45,879
-1% -$20.5M 0.13% 170
2017
Q2
$1.62B Sell
3,290,303
-89,848
-3% -$44.1M 0.14% 149
2017
Q1
$1.31B Buy
3,380,151
+139,602
+4% +$54.1M 0.12% 185
2016
Q4
$1.19B Buy
3,240,549
+68,675
+2% +$25.2M 0.11% 196
2016
Q3
$1.28B Buy
3,171,874
+78,579
+3% +$31.6M 0.13% 169
2016
Q2
$1.08B Buy
3,093,295
+15,272
+0.5% +$5.33M 0.12% 185
2016
Q1
$1.11B Buy
3,078,023
+233
+0% +$84K 0.12% 178
2015
Q4
$1.67B Buy
3,077,790
+47,975
+2% +$26M 0.18% 117
2015
Q3
$1.41B Buy
3,029,815
+5,220
+0.2% +$2.43M 0.16% 127
2015
Q2
$1.54B Sell
3,024,595
-95,229
-3% -$48.6M 0.16% 131
2015
Q1
$1.41B Sell
3,119,824
-72,230
-2% -$32.6M 0.14% 149
2014
Q4
$1.31B Buy
3,192,054
+53,497
+2% +$21.9M 0.13% 171
2014
Q3
$1.13B Sell
3,138,557
-90,714
-3% -$32.7M 0.12% 183
2014
Q2
$912M Sell
3,229,271
-24,884
-0.8% -$7.03M 0.1% 211
2014
Q1
$977M Sell
3,254,155
-113,979
-3% -$34.2M 0.11% 195
2013
Q4
$927M Buy
3,368,134
+98,441
+3% +$27.1M 0.1% 201
2013
Q3
$1.02B Buy
3,269,693
+9,633
+0.3% +$3.01M 0.13% 171
2013
Q2
$733M Buy
+3,260,060
New +$733M 0.1% 210